Virology has received significant attention as an area of study and research, with researchers learning about the transmission of viruses including HIV, Ebola, influenza, Zica, and SARS or SARS-CoV-2, commonly known as the coronavirus. Scientists are scrambling to keep up with coronavirus variants that appear to be evolving at an alarming rate, spreading and adapting to the most cutting-edge treatments. As a response, the need for efficient, comprehensive, and robust diagnostic procedures has never been higher. Traditional clinical tests are being enhanced constantly, however, they still provide limited information. With this objective, many virology technology companies are helping virologists develop evidence-based best practices to develop quicker, simpler, and more reliable vaccines.
This year is undeniably turning out to be a promising one in terms of technological advancements. Numerous technological advances have already yielded success, as seen by the growing technological vaccines and diagnostics developed by various corporations to aid humanity in containing the Covid-19 crisis. Efforts have been made on tools and approaches that are creating a buzz in the virology domain, ranging from vaccine breakthroughs to olfaction, neurology to mass spectrometry.
At this juncture, there is a wide variety of virology tech solution providers entering the industry with a set of advanced and integrated offerings. To help companies navigate through the best-of-breed solution providers, Pharma Tech Outlook Europe has compiled a list of the leading players in the field. This edition also offers thought leadership from subject-matter experts on the industry trends, best practices, and recent innovations.
We present Pharma Tech Outlook Europe’s “Top 5 Virology Solution Providers in UK 2021”.
